martes, 1 de julio de 2014

National Guideline Clearinghouse | Safe administration of systemic cancer therapy. Part 2: administration of chemotherapy and management of preventable adverse events.

full-text ►

National Guideline Clearinghouse | Safe administration of systemic cancer therapy. Part 2: administration of chemotherapy and management of preventable adverse events.

Program in Evidence-based Care

Cancer Care Ontario

National Guideline Clearinghouse (NGC)



Guideline Title
Safe administration of systemic cancer therapy. Part 2: administration of chemotherapy and management of preventable adverse events.
Bibliographic Source(s)
Leung M, Bland R, Baldassarre F, Green E, Kaizer L, Hertz S, Craven J, Trudeau M, Boudreau A, Cheung M, Singh S, Kukreti V, Raha R, Safe Administration of Chemotherapy Expert Panel. Safe administration of systemic cancer therapy. Part 2: administration of chemotherapy and management of preventable adverse events. Toronto (ON): Cancer Care Ontario (CCO); 2014 Mar 10. 82 p. (Evidence-based series; no. 12-12-2).  [95 references]
Guideline Status
This is the current release of the guideline.
The EVIDENCE-BASED SERIES report, initially the full original Guideline, over time will expand to contain new information emerging from reviewing and updating activities.
Please visit the Cancer Care Ontario Web site External Web Site Policy for details on any new evidence that has emerged and implications to the guidelines.

No hay comentarios:

Publicar un comentario